[1]
|
Hooi, J.K.Y., Lai, W.Y., Ng, W.K., et al. (2017) Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology, 153, 420-429. https://doi.org/10.1053/j.gastro.2017.04.022
|
[2]
|
Chhetri, J.K., Mei, S., Wang, C., et al. (2023) New Horizons in Parkinson’s Disease in Older Populations. Age and Ageing, 52, afad186. https://doi.org/10.1093/ageing/afad186
|
[3]
|
李淑华, 陈海波. 我国近十年帕金森病研究进展回顾与展望[J]. 中国神经免疫学和神经病学杂志, 2023, 30(1): 3-9.
|
[4]
|
任红丹, 闫咏梅, 周粉峰. 帕金森病运动并发症的影响因素及预防研究进展[J]. 预防医学, 2021, 33(4): 364-368.
|
[5]
|
Yu, H., Chang, Q., Sun, T., et al. (2023) Metabolic Reprogramming and Polarization of Microglia in Parkinson’s Disease: Role of Inflammasome and Iron. Age-ing Research Reviews, 90, Article 102032.
https://doi.org/10.1016/j.arr.2023.102032
|
[6]
|
Moustafa, S.A., Mohamed, S., Dawood, A., et al. (2021) Gut Brain Axis: An Insight into Microbiota Role in Parkinson’s Disease. Metabolic Brain Disease, 36, 1545-1557. https://doi.org/10.1007/s11011-021-00808-2
|
[7]
|
Jin, M., Wang, S., Gao, X., et al. (2024) Pathological and Physi-ological Functional Cross-Talks of α-Synuclein and Tau in the Central Nervous System. Neural Regeneration Research, 19, 855-862.
https://doi.org/10.4103/1673-5374.382231
|
[8]
|
Alabi, A.O., Ajayi, A.M., Ben-Azu, B., et al. (2019) Methyl Jasmonate Abrogates Rotenone-Induced Parkinsonian-Like Symptoms through Inhibition of Oxidative Stress, Release of Pro-Inflammatory Cytokines, and Down-Regulation of Immnopositive Cells of NF-kappaB and Alpha-Synuclein Ex-pressions in Mice. Neurotoxicology, 74, 172-183.
https://doi.org/10.1016/j.neuro.2019.07.003
|
[9]
|
Umemoto, G. and Furuya, H. (2020) Management of Dysphagia in Patients with Parkinson’s Disease and Related Disorders. Internal Medicine, 59, 7-14. https://doi.org/10.2169/internalmedicine.2373-18
|
[10]
|
Lolekha, P., Sriphanom, T. and Vilaichone, R.K. (2021) Helicobacter pylori Eradication Improves Motor Fluctuations in Advanced Parkinson’s Disease Patients: A Prospective Cohort Study (HP-PD Trial). PLOS ONE, 16, e0251042.
https://doi.org/10.1371/journal.pone.0251042
|
[11]
|
Tan, A.H., Lim, S.Y., Mahadeva, S., et al. (2020) Helicobacter pylori Eradication in Parkinson’s Disease: A Randomized Placebo-Controlled Trial. Movement Disorders, 35, 2250-2260. https://doi.org/10.1002/mds.28248
|
[12]
|
Chen, Z., Rasheed, M. and Deng, Y. (2022) The Epigenetic Mechanisms Involved in Mitochondrial Dysfunction: Implication for Parkinson’s Disease. Brain Pathology, 32, e13012. https://doi.org/10.1111/bpa.13012
|
[13]
|
Konovalova, J., Gerasymchuk, D., Parkkinen, I., et al. (2019) Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases. International Journal of Molecular Sciences, 20, Article 6055.
https://doi.org/10.3390/ijms20236055
|
[14]
|
Qadri, R., Goyal, V., Behari, M., et al. (2021) Alteration of Mitochon-drial Function in Oxidative Stress in Parkinsonian Neurodegeneration: A Cross-Sectional Study. Annals of Indian Academy of Neurology, 24, 506-512.
https://doi.org/10.4103/aian.AIAN_392_20
|
[15]
|
赵丽丽, 张硕, 陈莹, 等. 血浆同型半胱氨酸、血尿酸在帕金森病中表达水平的研究[J]. 中国实验诊断学, 2022, 26(1): 1-4.
|
[16]
|
Isik, S., Yeman Kiyak, B., Akbayir, R., et al. (2023) Microglia Mediated Neuroinflammation in Parkinson’s Disease. Cells, 12, Article 1012. https://doi.org/10.3390/cells12071012
|
[17]
|
Esteves, A.R., Silva, D.F., Banha, D., et al. (2023) LPS-Induced Mi-tochondrial Dysfunction Regulates Innate Immunity Activation and α-Synuclein Oligomerization in Parkinson’s Disease. Redox Biology, 63, Article 102714.
https://doi.org/10.1016/j.redox.2023.102714
|
[18]
|
He, J.Y., Li, D.D., Wen, Q., et al. (2023) Synergistic Effects of Lipopolysaccharide and Rotenone on Dopamine Neuronal Damage in Rats. CNS Neuroscience & Therapeutics, 29, 2281-2291. https://doi.org/10.1111/cns.14180
|
[19]
|
罗晨, 肖波, 刘人恺, 等. 幽门螺旋杆菌感染对帕金森病患者血清氧化应激状态及血小板线粒体功能的影响[J]. 中国神经免疫学和神经病学杂志, 2008, 15(5): 342-345, 348.
|
[20]
|
温雅, 王珊, 刘琦, 等. 帕金森病病人血清白细胞介素-6、白细胞介素-1β及肿瘤坏死因子α水平变化及其临床意义[J]. 安徽医药, 2022, 26(1): 54-57.
|
[21]
|
Shamsdin, S.A., Khazraei, H., Rahimi Jaberi, A., et al. (2022) Evaluation of Inflammatory Cytokine and Anti Helicobacter pylori Antibodies in the Pathogenesis of Parkinson’s Dis-ease. Middle East Journal of Digestive Diseases, 14, 96-102. https://doi.org/10.34172/mejdd.2022.261
|
[22]
|
Sarkar, S. (2022) Microglial Ion Channels: Key Players in Non-Cell Autonomous Neurodegeneration. Neurobiology of Disease, 174, Article 105861. https://doi.org/10.1016/j.nbd.2022.105861
|
[23]
|
Lim, M.C.C., Jantaree, P. and Naumann, M. (2023) The Conundrum of Helicobacter pylori-Associated Apoptosis in Gastric Cancer. Trends in Cancer, 9, 679-690. https://doi.org/10.1016/j.trecan.2023.04.012
|
[24]
|
Losurdo, G., Salvatore D’Abramo, F., Indellicati, G., et al. (2020) The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders. International Journal of Molecular Sciences, 21, Article 3531.
https://doi.org/10.3390/ijms21103531
|
[25]
|
Nyholm, D. and Hellstrom, P.M. (2021) Effects of Helicobacter pylori on Levodopa Pharmacokinetics. Journal of Parkinson’s Disease, 11, 61-69. https://doi.org/10.3233/JPD-202298
|
[26]
|
曹羽. 青海地区幽门螺杆菌感染对帕金森病影响的研究[D]: [硕士学位论文]. 西宁: 青海大学, 2020.
|
[27]
|
Leta, V., Klingelhoefer, L., Longardner, K., et al. (2023) Gastrointestinal Barri-ers to Levodopa Transport and Absorption in Parkinson’s Disease. European Journal of Neurology, 30, 1465-1480. https://doi.org/10.1111/ene.15734
|
[28]
|
Mohammadzadeh, R., Menbari, S., Pishdadian, A., et al. (2023) Helicobac-ter pylori Virulence Factors: Subversion of Host Immune System and Development of Various Clinical Outcomes. Ex-pert Reviews in Molecular Medicine, 25, e23. https://doi.org/10.1017/erm.2023.17
|
[29]
|
Chauhan, N., Tay, A.C.Y., Marshall, B.J., et al. (2019) Helicobacter pylori VacA, a Distinct Toxin Exerts Diverse Functionalities in Numerous Cells: An Overview. Helicobacter, 24, e12544. https://doi.org/10.1111/hel.12544
|
[30]
|
Garcia-Sanz, P.J., Aerts J.M.F.G. and Moratalla, R. (2021) The Role of Cholesterol in Alpha-Synuclein and Lewy Body Pathology in GBA1 Parkinson’s Disease. Movement Disorders, 36, 1070-1085.
https://doi.org/10.1002/mds.28396
|
[31]
|
Narmashiri, A., Abbaszadeh, M. and Ghazizadeh, A. (2022) The Effects of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the Cognitive and Motor Functions in Rodents: A Systematic Review and Meta-Analysis. Neuroscience and Biobehavioral Reviews, 140, Article 104792. https://doi.org/10.1016/j.neubiorev.2022.104792
|
[32]
|
Chao, Y.X., Gulam, M.Y., Chia, N.S.J., et al. (2020) Gut-Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson’s Disease. Frontiers in Neurology, 11, Ar-ticle 849. https://doi.org/10.3389/fneur.2020.00849
|
[33]
|
Shannon, K.M., Bloem, B.R., Brundin, P., et al. (2022) Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease. Journal of Parkinson’s Disease, 12, S45-S51. https://doi.org/10.3233/JPD-223271
|
[34]
|
Chen, Q.Q., Haikal, C., Li, W., et al. (2019) Gut Inflammation in Association with Pathogenesis of Parkinson’s Disease. Frontiers in Molecular Neuroscience, 12, Article 218. https://doi.org/10.3389/fnmol.2019.00218
|
[35]
|
Lubomski, M., Tan, A.H., Lim, S.Y., et al. (2020) Parkin-son’s Disease and the Gastrointestinal Microbiome. Journal of Neurology, 267, 2507-2523. https://doi.org/10.1007/s00415-019-09320-1
|
[36]
|
Hayes, M.T. (2019) Parkinson’s Disease and Parkinsonism. The American Journal of Medicine, 132, 802-807.
https://doi.org/10.1016/j.amjmed.2019.03.001
|
[37]
|
Heim, B., Peball, M., Hammermeister, J., et al. (2022) Differ-entiating Parkinson’s Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Me-ta-Analysis. Journal of Parkinson’s Disease, 12, 1115-1123. https://doi.org/10.3233/JPD-213012
|